A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Chronic Lymphocytic Leukemia (CLL)
- Cutaneous T Cell Lymphoma (CTCL)
- DLBCL
- Follicular Lymphoma
- Hodgkin Lymphoma
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma
- Peripheral T Cell Lymphoma (PTCL)
- Small Lymphocytic Lymphoma (SLL)
- Waldenstrom Macroglobulinemia
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04072458
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon